nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—Dapsone—systemic lupus erythematosus	0.314	1	CrCtD
Sulfamethoxazole—NAT2—systemic lupus erythematosus	0.177	0.863	CbGaD
Sulfamethoxazole—NAT2—Dapsone—systemic lupus erythematosus	0.0855	0.456	CbGbCtD
Sulfamethoxazole—ALB—systemic lupus erythematosus	0.028	0.136	CbGaD
Sulfamethoxazole—UGT1A9—Mycophenolate mofetil—systemic lupus erythematosus	0.0216	0.115	CbGbCtD
Sulfamethoxazole—Sulfacytine—Dapsone—systemic lupus erythematosus	0.0147	0.066	CrCrCtD
Sulfamethoxazole—Sulfadimethoxine—Dapsone—systemic lupus erythematosus	0.0147	0.066	CrCrCtD
Sulfamethoxazole—Sulfamoxole—Dapsone—systemic lupus erythematosus	0.0147	0.066	CrCrCtD
Sulfamethoxazole—Sulfamethazine—Dapsone—systemic lupus erythematosus	0.0147	0.066	CrCrCtD
Sulfamethoxazole—Sulfadoxine—Dapsone—systemic lupus erythematosus	0.0147	0.066	CrCrCtD
Sulfamethoxazole—Sulfathiazole—Dapsone—systemic lupus erythematosus	0.0147	0.066	CrCrCtD
Sulfamethoxazole—Silver sulfadiazine—Dapsone—systemic lupus erythematosus	0.0147	0.066	CrCrCtD
Sulfamethoxazole—Sulfisoxazole—Dapsone—systemic lupus erythematosus	0.0147	0.066	CrCrCtD
Sulfamethoxazole—Sulfamethizole—Dapsone—systemic lupus erythematosus	0.0147	0.066	CrCrCtD
Sulfamethoxazole—Sulfametopyrazine—Dapsone—systemic lupus erythematosus	0.0141	0.063	CrCrCtD
Sulfamethoxazole—Sulfamerazine—Dapsone—systemic lupus erythematosus	0.0141	0.063	CrCrCtD
Sulfamethoxazole—Sulfaphenazole—Dapsone—systemic lupus erythematosus	0.0135	0.0604	CrCrCtD
Sulfamethoxazole—Sulfadiazine—Dapsone—systemic lupus erythematosus	0.0135	0.0604	CrCrCtD
Sulfamethoxazole—Sulfanilamide—Dapsone—systemic lupus erythematosus	0.0129	0.0579	CrCrCtD
Sulfamethoxazole—NAT1—Acetylation—NAT2—systemic lupus erythematosus	0.0128	0.656	CbGpPWpGaD
Sulfamethoxazole—Sulfapyridine—Dapsone—systemic lupus erythematosus	0.0124	0.0557	CrCrCtD
Sulfamethoxazole—PTGS1—Dapsone—systemic lupus erythematosus	0.0103	0.0552	CbGbCtD
Sulfamethoxazole—Sulfacetamide—Dapsone—systemic lupus erythematosus	0.0102	0.0456	CrCrCtD
Sulfamethoxazole—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0067	0.0357	CbGbCtD
Sulfamethoxazole—CYP2C8—Dapsone—systemic lupus erythematosus	0.00597	0.0318	CbGbCtD
Sulfamethoxazole—CYP2C9—Leflunomide—systemic lupus erythematosus	0.00585	0.0312	CbGbCtD
Sulfamethoxazole—ALB—Prednisone—systemic lupus erythematosus	0.00536	0.0286	CbGbCtD
Sulfamethoxazole—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.00518	0.0276	CbGbCtD
Sulfamethoxazole—NAT2—urine—systemic lupus erythematosus	0.00417	0.265	CbGeAlD
Sulfamethoxazole—CYP2C9—Dapsone—systemic lupus erythematosus	0.00416	0.0222	CbGbCtD
Sulfamethoxazole—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00415	0.0222	CbGbCtD
Sulfamethoxazole—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00392	0.0209	CbGbCtD
Sulfamethoxazole—CYP2C9—cardial valve—systemic lupus erythematosus	0.003	0.191	CbGeAlD
Sulfamethoxazole—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00277	0.0148	CbGbCtD
Sulfamethoxazole—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00274	0.0146	CbGbCtD
Sulfamethoxazole—ALB—Methotrexate—systemic lupus erythematosus	0.00269	0.0143	CbGbCtD
Sulfamethoxazole—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00258	0.0138	CbGbCtD
Sulfamethoxazole—CYP3A4—Dapsone—systemic lupus erythematosus	0.00242	0.0129	CbGbCtD
Sulfamethoxazole—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0021	0.0112	CbGbCtD
Sulfamethoxazole—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0021	0.0112	CbGbCtD
Sulfamethoxazole—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0018	0.00961	CbGbCtD
Sulfamethoxazole—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0018	0.00961	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00178	0.00948	CbGbCtD
Sulfamethoxazole—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00169	0.00899	CbGbCtD
Sulfamethoxazole—CYP3A4—Prednisone—systemic lupus erythematosus	0.00168	0.00895	CbGbCtD
Sulfamethoxazole—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00159	0.00849	CbGbCtD
Sulfamethoxazole—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00105	0.00559	CbGbCtD
Sulfamethoxazole—NAT1—nephron tubule—systemic lupus erythematosus	0.00102	0.0649	CbGeAlD
Sulfamethoxazole—NAT1—cortex of kidney—systemic lupus erythematosus	0.000873	0.0556	CbGeAlD
Sulfamethoxazole—UGT1A9—Arylamine metabolism—NAT2—systemic lupus erythematosus	0.000769	0.0394	CbGpPWpGaD
Sulfamethoxazole—NAT1—tendon—systemic lupus erythematosus	0.000724	0.0461	CbGeAlD
Sulfamethoxazole—NAT1—bone marrow—systemic lupus erythematosus	0.000701	0.0446	CbGeAlD
Sulfamethoxazole—CYP2C9—urine—systemic lupus erythematosus	0.000648	0.0412	CbGeAlD
Sulfamethoxazole—NAT1—lung—systemic lupus erythematosus	0.000635	0.0404	CbGeAlD
Sulfamethoxazole—NAT1—Phase II conjugation—NAT2—systemic lupus erythematosus	0.000621	0.0318	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—kidney—systemic lupus erythematosus	0.000532	0.0339	CbGeAlD
Sulfamethoxazole—CYP3A4—urine—systemic lupus erythematosus	0.000494	0.0314	CbGeAlD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.000381	0.0195	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—blood plasma—systemic lupus erythematosus	0.000381	0.0242	CbGeAlD
Sulfamethoxazole—NAT1—Biological oxidations—NAT2—systemic lupus erythematosus	0.000363	0.0186	CbGpPWpGaD
Sulfamethoxazole—PTGS1—endothelium—systemic lupus erythematosus	0.000348	0.0221	CbGeAlD
Sulfamethoxazole—CYP2C9—blood plasma—systemic lupus erythematosus	0.000338	0.0215	CbGeAlD
Sulfamethoxazole—PTGS1—blood plasma—systemic lupus erythematosus	0.000309	0.0196	CbGeAlD
Sulfamethoxazole—CYP3A4—blood plasma—systemic lupus erythematosus	0.000258	0.0164	CbGeAlD
Sulfamethoxazole—Dapsone—NAT2—systemic lupus erythematosus	0.000234	0.404	CrCbGaD
Sulfamethoxazole—NAT1—Biological oxidations—RXRA—systemic lupus erythematosus	0.000204	0.0104	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—kidney—systemic lupus erythematosus	0.000173	0.011	CbGeAlD
Sulfamethoxazole—PTGS1—connective tissue—systemic lupus erythematosus	0.000164	0.0105	CbGeAlD
Sulfamethoxazole—PTGS1—skin of body—systemic lupus erythematosus	0.000148	0.00944	CbGeAlD
Sulfamethoxazole—PTGS1—kidney—systemic lupus erythematosus	0.00014	0.0089	CbGeAlD
Sulfamethoxazole—UGT1A9—PPAR Alpha Pathway—RXRA—systemic lupus erythematosus	0.000133	0.00683	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—kidney—systemic lupus erythematosus	0.000117	0.00744	CbGeAlD
Sulfamethoxazole—PTGS1—tendon—systemic lupus erythematosus	0.000113	0.00719	CbGeAlD
Sulfamethoxazole—UGT1A9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000113	0.00578	CbGpPWpGaD
Sulfamethoxazole—Sulfamethazine—ALB—systemic lupus erythematosus	0.000111	0.192	CrCbGaD
Sulfamethoxazole—Sulfamerazine—ALB—systemic lupus erythematosus	0.000109	0.187	CrCbGaD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000103	0.0053	CbGpPWpGaD
Sulfamethoxazole—ALB—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000103	0.00527	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000102	0.00522	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000102	0.00521	CbGpPWpGaD
Sulfamethoxazole—PTGS1—lung—systemic lupus erythematosus	9.92e-05	0.00631	CbGeAlD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	9.64e-05	0.00493	CbGpPWpGaD
Sulfamethoxazole—PTGS1—nervous system—systemic lupus erythematosus	9.18e-05	0.00584	CbGeAlD
Sulfamethoxazole—UGT1A9—Phase II conjugation—NAT2—systemic lupus erythematosus	8.97e-05	0.00459	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	8.86e-05	0.00453	CbGpPWpGaD
Sulfamethoxazole—PTGS1—central nervous system—systemic lupus erythematosus	8.84e-05	0.00562	CbGeAlD
Sulfamethoxazole—NAT2—Biological oxidations—RXRA—systemic lupus erythematosus	8.45e-05	0.00433	CbGpPWpGaD
Sulfamethoxazole—Sulfamethizole—ALB—systemic lupus erythematosus	8.42e-05	0.145	CrCbGaD
Sulfamethoxazole—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	8.09e-05	0.00414	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—nervous system—systemic lupus erythematosus	7.67e-05	0.00488	CbGeAlD
Sulfamethoxazole—CYP3A4—central nervous system—systemic lupus erythematosus	7.38e-05	0.0047	CbGeAlD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	6.94e-05	0.00355	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—NAT2—systemic lupus erythematosus	6.21e-05	0.00318	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	5.76e-05	0.00295	CbGpPWpGaD
Sulfamethoxazole—ALB—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	5.38e-05	0.00275	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Biological oxidations—NAT2—systemic lupus erythematosus	5.25e-05	0.00269	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	5.17e-05	0.00265	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—CLU—systemic lupus erythematosus	5.07e-05	0.00259	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	4.84e-05	0.00248	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	4.84e-05	0.00248	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—CLU—systemic lupus erythematosus	4.83e-05	0.00247	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	4.81e-05	0.00246	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	4.79e-05	0.00245	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	4.68e-05	0.0024	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.51e-05	0.00231	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	4.38e-05	0.00224	CbGpPWpGaD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	4.35e-05	0.00223	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	4.28e-05	0.00219	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—PPARA activates gene expression—RXRA—systemic lupus erythematosus	4.21e-05	0.00215	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	4.18e-05	0.00214	CbGpPWpGaD
Sulfamethoxazole—Dapsone—PTGS2—systemic lupus erythematosus	4.15e-05	0.0716	CrCbGaD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	4.12e-05	0.00211	CbGpPWpGaD
Sulfamethoxazole—Decreased appetite—Cyclosporine—systemic lupus erythematosus	4.02e-05	0.00119	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Methotrexate—systemic lupus erythematosus	4e-05	0.00118	CcSEcCtD
Sulfamethoxazole—Infestation—Methotrexate—systemic lupus erythematosus	4e-05	0.00118	CcSEcCtD
Sulfamethoxazole—Rash—Azathioprine—systemic lupus erythematosus	4e-05	0.00118	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	4e-05	0.00118	CcSEcCtD
Sulfamethoxazole—Dermatitis—Azathioprine—systemic lupus erythematosus	3.99e-05	0.00118	CcSEcCtD
Sulfamethoxazole—Depression—Methotrexate—systemic lupus erythematosus	3.99e-05	0.00118	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	3.99e-05	0.00118	CcSEcCtD
Sulfamethoxazole—Skin disorder—Hydrocortisone—systemic lupus erythematosus	3.99e-05	0.00118	CcSEcCtD
Sulfamethoxazole—Fatigue—Cyclosporine—systemic lupus erythematosus	3.98e-05	0.00118	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	3.97e-05	0.00203	CbGpPWpGaD
Sulfamethoxazole—Headache—Azathioprine—systemic lupus erythematosus	3.97e-05	0.00117	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	3.97e-05	0.00117	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	3.97e-05	0.00117	CcSEcCtD
Sulfamethoxazole—Dizziness—Leflunomide—systemic lupus erythematosus	3.96e-05	0.00117	CcSEcCtD
Sulfamethoxazole—Renal failure—Methotrexate—systemic lupus erythematosus	3.94e-05	0.00116	CcSEcCtD
Sulfamethoxazole—Angioedema—Dexamethasone—systemic lupus erythematosus	3.93e-05	0.00116	CcSEcCtD
Sulfamethoxazole—Angioedema—Betamethasone—systemic lupus erythematosus	3.93e-05	0.00116	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	3.92e-05	0.00116	CcSEcCtD
Sulfamethoxazole—Anorexia—Hydrocortisone—systemic lupus erythematosus	3.91e-05	0.00116	CcSEcCtD
Sulfamethoxazole—Stomatitis—Methotrexate—systemic lupus erythematosus	3.9e-05	0.00115	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	3.89e-05	0.00115	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	3.89e-05	0.00199	CbGpPWpGaD
Sulfamethoxazole—Immune system disorder—Prednisone—systemic lupus erythematosus	3.88e-05	0.00115	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	3.87e-05	0.00114	CcSEcCtD
Sulfamethoxazole—Vertigo—Betamethasone—systemic lupus erythematosus	3.86e-05	0.00114	CcSEcCtD
Sulfamethoxazole—Vertigo—Dexamethasone—systemic lupus erythematosus	3.86e-05	0.00114	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	3.86e-05	0.00114	CcSEcCtD
Sulfamethoxazole—Vomiting—Leflunomide—systemic lupus erythematosus	3.81e-05	0.00112	CcSEcCtD
Sulfamethoxazole—Insomnia—Prednisolone—systemic lupus erythematosus	3.8e-05	0.00112	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	3.79e-05	0.00112	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	3.78e-05	0.00112	CcSEcCtD
Sulfamethoxazole—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	3.78e-05	0.00194	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	3.78e-05	0.00112	CcSEcCtD
Sulfamethoxazole—Rash—Leflunomide—systemic lupus erythematosus	3.77e-05	0.00111	CcSEcCtD
Sulfamethoxazole—Dermatitis—Leflunomide—systemic lupus erythematosus	3.77e-05	0.00111	CcSEcCtD
Sulfamethoxazole—Mental disorder—Prednisone—systemic lupus erythematosus	3.77e-05	0.00111	CcSEcCtD
Sulfamethoxazole—Nausea—Azathioprine—systemic lupus erythematosus	3.77e-05	0.00111	CcSEcCtD
Sulfamethoxazole—Headache—Leflunomide—systemic lupus erythematosus	3.75e-05	0.00111	CcSEcCtD
Sulfamethoxazole—Skin disorder—Methylprednisolone—systemic lupus erythematosus	3.75e-05	0.00111	CcSEcCtD
Sulfamethoxazole—Malnutrition—Prednisone—systemic lupus erythematosus	3.74e-05	0.00111	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	3.74e-05	0.0011	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Methotrexate—systemic lupus erythematosus	3.74e-05	0.0011	CcSEcCtD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	3.74e-05	0.00191	CbGpPWpGaD
Sulfamethoxazole—Convulsion—Dexamethasone—systemic lupus erythematosus	3.72e-05	0.0011	CcSEcCtD
Sulfamethoxazole—Convulsion—Betamethasone—systemic lupus erythematosus	3.72e-05	0.0011	CcSEcCtD
Sulfamethoxazole—Insomnia—Hydrocortisone—systemic lupus erythematosus	3.71e-05	0.0011	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	3.69e-05	0.00109	CcSEcCtD
Sulfamethoxazole—Urticaria—Cyclosporine—systemic lupus erythematosus	3.67e-05	0.00108	CcSEcCtD
Sulfamethoxazole—Myalgia—Dexamethasone—systemic lupus erythematosus	3.66e-05	0.00108	CcSEcCtD
Sulfamethoxazole—Myalgia—Betamethasone—systemic lupus erythematosus	3.66e-05	0.00108	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Cyclosporine—systemic lupus erythematosus	3.65e-05	0.00108	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Cyclosporine—systemic lupus erythematosus	3.65e-05	0.00108	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	3.61e-05	0.00107	CcSEcCtD
Sulfamethoxazole—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	3.6e-05	0.00184	CbGpPWpGaD
Sulfamethoxazole—Hepatitis—Methotrexate—systemic lupus erythematosus	3.59e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	3.58e-05	0.00106	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	3.57e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	3.56e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	3.56e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Nausea—Leflunomide—systemic lupus erythematosus	3.56e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	3.55e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	3.55e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Fatigue—Hydrocortisone—systemic lupus erythematosus	3.54e-05	0.00105	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Methotrexate—systemic lupus erythematosus	3.52e-05	0.00104	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	3.52e-05	0.00104	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	3.51e-05	0.00104	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	3.51e-05	0.00104	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	3.51e-05	0.00104	CcSEcCtD
Sulfamethoxazole—Insomnia—Triamcinolone—systemic lupus erythematosus	3.5e-05	0.00103	CcSEcCtD
Sulfamethoxazole—Insomnia—Methylprednisolone—systemic lupus erythematosus	3.49e-05	0.00103	CcSEcCtD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	3.49e-05	0.00179	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—RXRA—systemic lupus erythematosus	3.48e-05	0.00178	CbGpPWpGaD
Sulfamethoxazole—Dyspnoea—Triamcinolone—systemic lupus erythematosus	3.45e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Betamethasone—systemic lupus erythematosus	3.44e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	3.44e-05	0.00102	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	3.44e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	3.44e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Angioedema—Prednisone—systemic lupus erythematosus	3.42e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	3.4e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Triamcinolone—systemic lupus erythematosus	3.4e-05	0.00101	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Methotrexate—systemic lupus erythematosus	3.4e-05	0.001	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	3.4e-05	0.001	CcSEcCtD
Sulfamethoxazole—Vertigo—Prednisone—systemic lupus erythematosus	3.36e-05	0.000993	CcSEcCtD
Sulfamethoxazole—Eye disorder—Methotrexate—systemic lupus erythematosus	3.36e-05	0.000992	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	3.36e-05	0.000992	CcSEcCtD
Sulfamethoxazole—UGT1A9—NRF2 pathway—RXRA—systemic lupus erythematosus	3.35e-05	0.00172	CbGpPWpGaD
Sulfamethoxazole—Tinnitus—Methotrexate—systemic lupus erythematosus	3.35e-05	0.00099	CcSEcCtD
Sulfamethoxazole—Anorexia—Dexamethasone—systemic lupus erythematosus	3.34e-05	0.000988	CcSEcCtD
Sulfamethoxazole—Anorexia—Betamethasone—systemic lupus erythematosus	3.34e-05	0.000988	CcSEcCtD
Sulfamethoxazole—Urticaria—Prednisolone—systemic lupus erythematosus	3.34e-05	0.000986	CcSEcCtD
Sulfamethoxazole—Fatigue—Triamcinolone—systemic lupus erythematosus	3.33e-05	0.000985	CcSEcCtD
Sulfamethoxazole—Fatigue—Methylprednisolone—systemic lupus erythematosus	3.33e-05	0.000982	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	3.32e-05	0.000981	CcSEcCtD
Sulfamethoxazole—Asthenia—Cyclosporine—systemic lupus erythematosus	3.32e-05	0.000979	CcSEcCtD
Sulfamethoxazole—Pruritus—Cyclosporine—systemic lupus erythematosus	3.27e-05	0.000965	CcSEcCtD
Sulfamethoxazole—Urticaria—Hydrocortisone—systemic lupus erythematosus	3.26e-05	0.000963	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Methotrexate—systemic lupus erythematosus	3.25e-05	0.000959	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.25e-05	0.000959	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.25e-05	0.000959	CcSEcCtD
Sulfamethoxazole—Convulsion—Prednisone—systemic lupus erythematosus	3.24e-05	0.000958	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000957	CcSEcCtD
Sulfamethoxazole—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.23e-05	0.000955	CcSEcCtD
Sulfamethoxazole—Chills—Methotrexate—systemic lupus erythematosus	3.22e-05	0.000952	CcSEcCtD
Sulfamethoxazole—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.2e-05	0.00164	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	3.2e-05	0.000944	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	3.2e-05	0.000944	CcSEcCtD
Sulfamethoxazole—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	3.19e-05	0.00163	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.19e-05	0.000942	CcSEcCtD
Sulfamethoxazole—Myalgia—Prednisone—systemic lupus erythematosus	3.19e-05	0.000941	CcSEcCtD
Sulfamethoxazole—Arthralgia—Prednisone—systemic lupus erythematosus	3.19e-05	0.000941	CcSEcCtD
Sulfamethoxazole—Insomnia—Dexamethasone—systemic lupus erythematosus	3.17e-05	0.000937	CcSEcCtD
Sulfamethoxazole—Insomnia—Betamethasone—systemic lupus erythematosus	3.17e-05	0.000937	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	3.17e-05	0.000935	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.16e-05	0.000934	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.15e-05	0.000932	CcSEcCtD
Sulfamethoxazole—Mental disorder—Methotrexate—systemic lupus erythematosus	3.15e-05	0.00093	CcSEcCtD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	3.13e-05	0.0016	CbGpPWpGaD
Sulfamethoxazole—Malnutrition—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000924	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.1e-05	0.000915	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.09e-05	0.000912	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.09e-05	0.000912	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.08e-05	0.000911	CcSEcCtD
Sulfamethoxazole—Urticaria—Triamcinolone—systemic lupus erythematosus	3.07e-05	0.000907	CcSEcCtD
Sulfamethoxazole—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.06e-05	0.000905	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.06e-05	0.000903	CcSEcCtD
Sulfamethoxazole—Dizziness—Cyclosporine—systemic lupus erythematosus	3.06e-05	0.000902	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Prednisone—systemic lupus erythematosus	3.06e-05	0.000902	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.05e-05	0.000901	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.05e-05	0.000901	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.05e-05	0.000901	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	3.04e-05	0.00155	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	3.03e-05	0.00155	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.03e-05	0.000895	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.03e-05	0.000895	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.03e-05	0.000894	CcSEcCtD
Sulfamethoxazole—Fatigue—Betamethasone—systemic lupus erythematosus	3.02e-05	0.000893	CcSEcCtD
Sulfamethoxazole—Fatigue—Dexamethasone—systemic lupus erythematosus	3.02e-05	0.000893	CcSEcCtD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—CRP—systemic lupus erythematosus	3.02e-05	0.00154	CbGpPWpGaD
Sulfamethoxazole—Nervous system disorder—Prednisone—systemic lupus erythematosus	3e-05	0.000885	CcSEcCtD
Sulfamethoxazole—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	2.98e-05	0.00088	CcSEcCtD
Sulfamethoxazole—Skin disorder—Prednisone—systemic lupus erythematosus	2.97e-05	0.000876	CcSEcCtD
Sulfamethoxazole—Asthenia—Hydrocortisone—systemic lupus erythematosus	2.95e-05	0.00087	CcSEcCtD
Sulfamethoxazole—UGT1A9—Biological oxidations—RXRA—systemic lupus erythematosus	2.94e-05	0.00151	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Cyclosporine—systemic lupus erythematosus	2.94e-05	0.000868	CcSEcCtD
Sulfamethoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	2.93e-05	0.0015	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.92e-05	0.00149	CbGpPWpGaD
Sulfamethoxazole—Rash—Cyclosporine—systemic lupus erythematosus	2.91e-05	0.00086	CcSEcCtD
Sulfamethoxazole—Anorexia—Prednisone—systemic lupus erythematosus	2.91e-05	0.00086	CcSEcCtD
Sulfamethoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	2.91e-05	0.00149	CbGpPWpGaD
Sulfamethoxazole—Dermatitis—Cyclosporine—systemic lupus erythematosus	2.91e-05	0.00086	CcSEcCtD
Sulfamethoxazole—Pruritus—Hydrocortisone—systemic lupus erythematosus	2.91e-05	0.000858	CcSEcCtD
Sulfamethoxazole—Headache—Cyclosporine—systemic lupus erythematosus	2.89e-05	0.000855	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	2.87e-05	0.000847	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	2.87e-05	0.000847	CcSEcCtD
Sulfamethoxazole—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	2.87e-05	0.000846	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	2.85e-05	0.000841	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	2.84e-05	0.000839	CcSEcCtD
Sulfamethoxazole—Rash—Mycophenolate mofetil—systemic lupus erythematosus	2.84e-05	0.000839	CcSEcCtD
Sulfamethoxazole—ALB—Folate Metabolism—IL4—systemic lupus erythematosus	2.84e-05	0.00145	CbGpPWpGaD
Sulfamethoxazole—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	2.84e-05	0.000839	CcSEcCtD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	2.84e-05	0.00145	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.83e-05	0.00145	CbGpPWpGaD
Sulfamethoxazole—Headache—Mycophenolate mofetil—systemic lupus erythematosus	2.82e-05	0.000834	CcSEcCtD
Sulfamethoxazole—Vertigo—Methotrexate—systemic lupus erythematosus	2.81e-05	0.00083	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	2.81e-05	0.00083	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	2.8e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—Leukopenia—Methotrexate—systemic lupus erythematosus	2.8e-05	0.000827	CcSEcCtD
Sulfamethoxazole—Urticaria—Betamethasone—systemic lupus erythematosus	2.79e-05	0.000823	CcSEcCtD
Sulfamethoxazole—Urticaria—Dexamethasone—systemic lupus erythematosus	2.79e-05	0.000823	CcSEcCtD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—F2—systemic lupus erythematosus	2.78e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	2.78e-05	0.000822	CcSEcCtD
Sulfamethoxazole—Dizziness—Prednisolone—systemic lupus erythematosus	2.78e-05	0.000821	CcSEcCtD
Sulfamethoxazole—Asthenia—Triamcinolone—systemic lupus erythematosus	2.77e-05	0.000819	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dexamethasone—systemic lupus erythematosus	2.77e-05	0.000819	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dexamethasone—systemic lupus erythematosus	2.77e-05	0.000819	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Betamethasone—systemic lupus erythematosus	2.77e-05	0.000819	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Betamethasone—systemic lupus erythematosus	2.77e-05	0.000819	CcSEcCtD
Sulfamethoxazole—Asthenia—Methylprednisolone—systemic lupus erythematosus	2.77e-05	0.000817	CcSEcCtD
Sulfamethoxazole—Insomnia—Prednisone—systemic lupus erythematosus	2.76e-05	0.000816	CcSEcCtD
Sulfamethoxazole—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	2.76e-05	0.00141	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	2.75e-05	0.00141	CbGpPWpGaD
Sulfamethoxazole—Nausea—Cyclosporine—systemic lupus erythematosus	2.74e-05	0.000811	CcSEcCtD
Sulfamethoxazole—Pruritus—Triamcinolone—systemic lupus erythematosus	2.74e-05	0.000808	CcSEcCtD
Sulfamethoxazole—Cough—Methotrexate—systemic lupus erythematosus	2.73e-05	0.000806	CcSEcCtD
Sulfamethoxazole—Pruritus—Methylprednisolone—systemic lupus erythematosus	2.73e-05	0.000806	CcSEcCtD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2.72e-05	0.00139	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.72e-05	0.000802	CcSEcCtD
Sulfamethoxazole—Convulsion—Methotrexate—systemic lupus erythematosus	2.71e-05	0.000801	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Prednisone—systemic lupus erythematosus	2.69e-05	0.000794	CcSEcCtD
Sulfamethoxazole—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.68e-05	0.000791	CcSEcCtD
Sulfamethoxazole—Arthralgia—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000787	CcSEcCtD
Sulfamethoxazole—Myalgia—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000787	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Prednisone—systemic lupus erythematosus	2.66e-05	0.000784	CcSEcCtD
Sulfamethoxazole—UGT1A9—PPARA activates gene expression—PPARG—systemic lupus erythematosus	2.66e-05	0.00136	CbGpPWpGaD
Sulfamethoxazole—Rash—Prednisolone—systemic lupus erythematosus	2.65e-05	0.000783	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisolone—systemic lupus erythematosus	2.65e-05	0.000782	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.65e-05	0.000781	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.64e-05	0.00078	CcSEcCtD
Sulfamethoxazole—Fatigue—Prednisone—systemic lupus erythematosus	2.63e-05	0.000778	CcSEcCtD
Sulfamethoxazole—Headache—Prednisolone—systemic lupus erythematosus	2.63e-05	0.000778	CcSEcCtD
Sulfamethoxazole—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.61e-05	0.000771	CcSEcCtD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	2.6e-05	0.00133	CbGpPWpGaD
Sulfamethoxazole—Rash—Hydrocortisone—systemic lupus erythematosus	2.59e-05	0.000765	CcSEcCtD
Sulfamethoxazole—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.59e-05	0.000764	CcSEcCtD
Sulfamethoxazole—Headache—Hydrocortisone—systemic lupus erythematosus	2.57e-05	0.00076	CcSEcCtD
Sulfamethoxazole—Dizziness—Triamcinolone—systemic lupus erythematosus	2.56e-05	0.000755	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.55e-05	0.000754	CcSEcCtD
Sulfamethoxazole—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.55e-05	0.000753	CcSEcCtD
Sulfamethoxazole—Asthenia—Dexamethasone—systemic lupus erythematosus	2.52e-05	0.000743	CcSEcCtD
Sulfamethoxazole—Asthenia—Betamethasone—systemic lupus erythematosus	2.52e-05	0.000743	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.5e-05	0.00074	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.5e-05	0.000738	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.5e-05	0.000738	CcSEcCtD
Sulfamethoxazole—Nausea—Prednisolone—systemic lupus erythematosus	2.5e-05	0.000738	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	2.5e-05	0.00128	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Dexamethasone—systemic lupus erythematosus	2.48e-05	0.000733	CcSEcCtD
Sulfamethoxazole—Pruritus—Betamethasone—systemic lupus erythematosus	2.48e-05	0.000733	CcSEcCtD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—CCL2—systemic lupus erythematosus	2.48e-05	0.00127	CbGpPWpGaD
Sulfamethoxazole—Skin disorder—Methotrexate—systemic lupus erythematosus	2.48e-05	0.000732	CcSEcCtD
Sulfamethoxazole—Vomiting—Triamcinolone—systemic lupus erythematosus	2.46e-05	0.000726	CcSEcCtD
Sulfamethoxazole—ALB—Folate Metabolism—CRP—systemic lupus erythematosus	2.45e-05	0.00126	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.45e-05	0.000724	CcSEcCtD
Sulfamethoxazole—Nausea—Hydrocortisone—systemic lupus erythematosus	2.44e-05	0.00072	CcSEcCtD
Sulfamethoxazole—Rash—Triamcinolone—systemic lupus erythematosus	2.44e-05	0.00072	CcSEcCtD
Sulfamethoxazole—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.44e-05	0.000719	CcSEcCtD
Sulfamethoxazole—Anorexia—Methotrexate—systemic lupus erythematosus	2.43e-05	0.000719	CcSEcCtD
Sulfamethoxazole—Rash—Methylprednisolone—systemic lupus erythematosus	2.43e-05	0.000718	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.43e-05	0.000718	CcSEcCtD
Sulfamethoxazole—Urticaria—Prednisone—systemic lupus erythematosus	2.43e-05	0.000717	CcSEcCtD
Sulfamethoxazole—Headache—Triamcinolone—systemic lupus erythematosus	2.42e-05	0.000715	CcSEcCtD
Sulfamethoxazole—Headache—Methylprednisolone—systemic lupus erythematosus	2.42e-05	0.000714	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Prednisone—systemic lupus erythematosus	2.42e-05	0.000713	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Prednisone—systemic lupus erythematosus	2.42e-05	0.000713	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.4e-05	0.000709	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.4e-05	0.000709	CcSEcCtD
Sulfamethoxazole—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	2.4e-05	0.00123	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.37e-05	0.00121	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	2.33e-05	0.00119	CbGpPWpGaD
Sulfamethoxazole—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.33e-05	0.000687	CcSEcCtD
Sulfamethoxazole—Dizziness—Betamethasone—systemic lupus erythematosus	2.32e-05	0.000685	CcSEcCtD
Sulfamethoxazole—Dizziness—Dexamethasone—systemic lupus erythematosus	2.32e-05	0.000685	CcSEcCtD
Sulfamethoxazole—Insomnia—Methotrexate—systemic lupus erythematosus	2.31e-05	0.000682	CcSEcCtD
Sulfamethoxazole—Nausea—Triamcinolone—systemic lupus erythematosus	2.3e-05	0.000678	CcSEcCtD
Sulfamethoxazole—Nausea—Methylprednisolone—systemic lupus erythematosus	2.29e-05	0.000677	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.28e-05	0.000672	CcSEcCtD
Sulfamethoxazole—ALB—Folate Metabolism—F2—systemic lupus erythematosus	2.26e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.25e-05	0.000665	CcSEcCtD
Sulfamethoxazole—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	2.25e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.25e-05	0.000664	CcSEcCtD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	2.25e-05	0.00115	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Dexamethasone—systemic lupus erythematosus	2.23e-05	0.000659	CcSEcCtD
Sulfamethoxazole—Vomiting—Betamethasone—systemic lupus erythematosus	2.23e-05	0.000659	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000656	CcSEcCtD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2.22e-05	0.00114	CbGpPWpGaD
Sulfamethoxazole—Rash—Dexamethasone—systemic lupus erythematosus	2.21e-05	0.000653	CcSEcCtD
Sulfamethoxazole—Rash—Betamethasone—systemic lupus erythematosus	2.21e-05	0.000653	CcSEcCtD
Sulfamethoxazole—Dermatitis—Betamethasone—systemic lupus erythematosus	2.21e-05	0.000653	CcSEcCtD
Sulfamethoxazole—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.21e-05	0.000653	CcSEcCtD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	2.21e-05	0.00113	CbGpPWpGaD
Sulfamethoxazole—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.2e-05	0.000651	CcSEcCtD
Sulfamethoxazole—Fatigue—Methotrexate—systemic lupus erythematosus	2.2e-05	0.00065	CcSEcCtD
Sulfamethoxazole—Headache—Dexamethasone—systemic lupus erythematosus	2.2e-05	0.000649	CcSEcCtD
Sulfamethoxazole—Headache—Betamethasone—systemic lupus erythematosus	2.2e-05	0.000649	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—PPARG—systemic lupus erythematosus	2.2e-05	0.00113	CbGpPWpGaD
Sulfamethoxazole—Asthenia—Prednisone—systemic lupus erythematosus	2.19e-05	0.000647	CcSEcCtD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	2.18e-05	0.00111	CbGpPWpGaD
Sulfamethoxazole—Pruritus—Prednisone—systemic lupus erythematosus	2.16e-05	0.000638	CcSEcCtD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	2.12e-05	0.00109	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IFNG—systemic lupus erythematosus	2.11e-05	0.00108	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Prednisone—systemic lupus erythematosus	2.09e-05	0.000617	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.09e-05	0.000617	CcSEcCtD
Sulfamethoxazole—Nausea—Dexamethasone—systemic lupus erythematosus	2.08e-05	0.000615	CcSEcCtD
Sulfamethoxazole—Nausea—Betamethasone—systemic lupus erythematosus	2.08e-05	0.000615	CcSEcCtD
Sulfamethoxazole—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.07e-05	0.00106	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	2.04e-05	0.00104	CbGpPWpGaD
Sulfamethoxazole—Urticaria—Methotrexate—systemic lupus erythematosus	2.03e-05	0.000599	CcSEcCtD
Sulfamethoxazole—Dizziness—Prednisone—systemic lupus erythematosus	2.02e-05	0.000597	CcSEcCtD
Sulfamethoxazole—ALB—Folate Metabolism—CCL2—systemic lupus erythematosus	2.02e-05	0.00103	CbGpPWpGaD
Sulfamethoxazole—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.02e-05	0.000596	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.02e-05	0.000596	CcSEcCtD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	2e-05	0.00103	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—ALB—systemic lupus erythematosus	1.98e-05	0.00101	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	1.95e-05	0.000998	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Prednisone—systemic lupus erythematosus	1.94e-05	0.000574	CcSEcCtD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	1.93e-05	0.000988	CbGpPWpGaD
Sulfamethoxazole—Rash—Prednisone—systemic lupus erythematosus	1.93e-05	0.000569	CcSEcCtD
Sulfamethoxazole—Dermatitis—Prednisone—systemic lupus erythematosus	1.92e-05	0.000568	CcSEcCtD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	1.92e-05	0.000983	CbGpPWpGaD
Sulfamethoxazole—Headache—Prednisone—systemic lupus erythematosus	1.91e-05	0.000565	CcSEcCtD
Sulfamethoxazole—NAT1—Metabolism—NOS3—systemic lupus erythematosus	1.89e-05	0.000968	CbGpPWpGaD
Sulfamethoxazole—Hypersensitivity—Methotrexate—systemic lupus erythematosus	1.88e-05	0.000556	CcSEcCtD
Sulfamethoxazole—Asthenia—Methotrexate—systemic lupus erythematosus	1.83e-05	0.000541	CcSEcCtD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	1.82e-05	0.000932	CbGpPWpGaD
Sulfamethoxazole—Nausea—Prednisone—systemic lupus erythematosus	1.81e-05	0.000536	CcSEcCtD
Sulfamethoxazole—Pruritus—Methotrexate—systemic lupus erythematosus	1.81e-05	0.000534	CcSEcCtD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—F2—systemic lupus erythematosus	1.8e-05	0.000921	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	1.79e-05	0.000917	CbGpPWpGaD
Sulfamethoxazole—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.75e-05	0.000516	CcSEcCtD
Sulfamethoxazole—UGT1A9—PPARA activates gene expression—EP300—systemic lupus erythematosus	1.74e-05	0.000889	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PTGS2—systemic lupus erythematosus	1.73e-05	0.000885	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IFNG—systemic lupus erythematosus	1.72e-05	0.000879	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	1.7e-05	0.00087	CbGpPWpGaD
Sulfamethoxazole—Dizziness—Methotrexate—systemic lupus erythematosus	1.69e-05	0.000499	CcSEcCtD
Sulfamethoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	1.68e-05	0.000861	CbGpPWpGaD
Sulfamethoxazole—Vomiting—Methotrexate—systemic lupus erythematosus	1.62e-05	0.000479	CcSEcCtD
Sulfamethoxazole—Rash—Methotrexate—systemic lupus erythematosus	1.61e-05	0.000475	CcSEcCtD
Sulfamethoxazole—Dermatitis—Methotrexate—systemic lupus erythematosus	1.61e-05	0.000475	CcSEcCtD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	1.6e-05	0.000821	CbGpPWpGaD
Sulfamethoxazole—Headache—Methotrexate—systemic lupus erythematosus	1.6e-05	0.000472	CcSEcCtD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.56e-05	0.000801	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	1.55e-05	0.000793	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL2—systemic lupus erythematosus	1.53e-05	0.000781	CbGpPWpGaD
Sulfamethoxazole—Nausea—Methotrexate—systemic lupus erythematosus	1.52e-05	0.000448	CcSEcCtD
Sulfamethoxazole—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	1.48e-05	0.000759	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.46e-05	0.000749	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—RXRA—systemic lupus erythematosus	1.45e-05	0.00074	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—EP300—systemic lupus erythematosus	1.44e-05	0.000736	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.37e-05	0.000703	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	1.37e-05	0.000699	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—TNF—systemic lupus erythematosus	1.37e-05	0.000699	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	1.36e-05	0.000698	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	1.31e-05	0.000669	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—ITGAX—systemic lupus erythematosus	1.3e-05	0.000665	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—F3—systemic lupus erythematosus	1.28e-05	0.000656	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	1.26e-05	0.000645	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—NRF2 pathway—TGFB1—systemic lupus erythematosus	1.2e-05	0.000616	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	1.17e-05	0.0006	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CLU—systemic lupus erythematosus	1.16e-05	0.000593	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.13e-05	0.000578	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—P2RY12—systemic lupus erythematosus	1.12e-05	0.000574	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—VEGFA—systemic lupus erythematosus	1.11e-05	0.000569	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TNF—systemic lupus erythematosus	1.11e-05	0.000569	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.11e-05	0.000568	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	1.1e-05	0.000564	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	1.06e-05	0.000542	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	1.06e-05	0.000542	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SELE—systemic lupus erythematosus	1.03e-05	0.000529	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CSK—systemic lupus erythematosus	1.03e-05	0.000529	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—TGFB1—systemic lupus erythematosus	1.02e-05	0.000522	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	9.89e-06	0.000507	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	9.72e-06	0.000497	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—ITGAM—systemic lupus erythematosus	9.71e-06	0.000497	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—LYN—systemic lupus erythematosus	9.38e-06	0.00048	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.21e-06	0.000471	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	9.2e-06	0.000471	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PPARG—systemic lupus erythematosus	9.13e-06	0.000467	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NAT2—systemic lupus erythematosus	8.97e-06	0.000459	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	8.96e-06	0.000459	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	8.83e-06	0.000452	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	8.61e-06	0.000441	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	8.31e-06	0.000426	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ALB—systemic lupus erythematosus	8.21e-06	0.00042	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—NOS3—systemic lupus erythematosus	7.85e-06	0.000402	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	7.31e-06	0.000374	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	7.23e-06	0.00037	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTGS2—systemic lupus erythematosus	7.18e-06	0.000367	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.13e-06	0.000365	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	7.12e-06	0.000365	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	7.04e-06	0.00036	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.41e-06	0.000328	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—EP300—systemic lupus erythematosus	5.97e-06	0.000306	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.95e-06	0.000304	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.91e-06	0.000303	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.81e-06	0.000298	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	5.8e-06	0.000297	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.62e-06	0.000288	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.61e-06	0.000287	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—JAK1—systemic lupus erythematosus	5.46e-06	0.00028	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.23e-06	0.000268	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	5.1e-06	0.000261	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—RXRA—systemic lupus erythematosus	5.03e-06	0.000257	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	4.93e-06	0.000252	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.84e-06	0.000248	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	4.72e-06	0.000242	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NAT2—systemic lupus erythematosus	4.7e-06	0.00024	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.66e-06	0.000239	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.57e-06	0.000234	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	4.52e-06	0.000232	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—F2—systemic lupus erythematosus	4.44e-06	0.000227	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	4.1e-06	0.00021	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	3.84e-06	0.000197	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.8e-06	0.000195	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.75e-06	0.000192	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.73e-06	0.000191	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS3—systemic lupus erythematosus	3.53e-06	0.000181	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.38e-06	0.000173	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPARG—systemic lupus erythematosus	3.18e-06	0.000163	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.06e-06	0.000156	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—systemic lupus erythematosus	2.99e-06	0.000153	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.95e-06	0.000151	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.94e-06	0.00015	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—systemic lupus erythematosus	2.86e-06	0.000146	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.75e-06	0.000141	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NOS3—systemic lupus erythematosus	2.73e-06	0.00014	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—EP300—systemic lupus erythematosus	2.68e-06	0.000137	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	2.65e-06	0.000136	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—RXRA—systemic lupus erythematosus	2.63e-06	0.000135	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	2.59e-06	0.000133	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	2.54e-06	0.00013	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	2.54e-06	0.00013	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—systemic lupus erythematosus	2.5e-06	0.000128	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.46e-06	0.000126	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.44e-06	0.000125	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.4e-06	0.000123	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	2.33e-06	0.000119	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—systemic lupus erythematosus	2.33e-06	0.000119	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	2.23e-06	0.000114	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	2.16e-06	0.00011	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—EP300—systemic lupus erythematosus	2.08e-06	0.000106	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	2.04e-06	0.000104	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2e-06	0.000102	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—EP300—systemic lupus erythematosus	1.69e-06	8.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	1.67e-06	8.56e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARG—systemic lupus erythematosus	1.66e-06	8.51e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	1.5e-06	7.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	1.44e-06	7.36e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.43e-06	7.32e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.42e-06	7.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.36e-06	6.97e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	1.32e-06	6.73e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.31e-06	6.7e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.22e-06	6.26e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.17e-06	5.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.09e-06	5.6e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—EP300—systemic lupus erythematosus	1.09e-06	5.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.07e-06	5.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	8.97e-07	4.59e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	8.9e-07	4.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	8.07e-07	4.13e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	7.72e-07	3.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	7.06e-07	3.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	5.87e-07	3.01e-05	CbGpPWpGaD
